Concerning phenotypical aspects of patients with NEK1 variants, clinical manifestations including age of onset, severity, and disease progression compared to sporadic ALS cases were not significantly different but only survival times were shorter in patients with NEK1 LOF variants (Fig. S9). This evidence concerns the gene NEK1 and amyotrophic lateral sclerosis.